Maternal ITP (Autoimmune Thrombocytopenia)

Maternal ITP vs NAIT Clarification

• Pathogenesis: Mother has an established autoimmune disorder (ITP or SLE). Maternal IgG autoantibody complex cross the placenta and destroy *both* maternal and fetal platelets.
• Strict Delineator: Mother will have THROMBOCYTOPENIA (unlike NAIT, where maternal platelets are completely normal).
• Infant severity: Typically less severe than NAIT. Only ~10% of neonates born to ITP mothers develop platelets < 50k, and rate of catastrophic Intracranial Hemorrhage (ICH) is very low (< 1%).
• The exact depth of neonatal thrombocytopenia does NOT strictly correlate to the depth of maternal thrombocytopenia or mode of delivery.

Rigorous Monitoring Protocol

• Obtain an exact cord blood platelet count at delivery.
• Nadir (lowest point) of platelet count in infant typically occurs between Day 2 and Day 5 of life as maternal reticuloendothelial system mapping clears existing infant platelets.
• Monitor daily CBC/platelet counts until a steady upward trend is firmly established for 48 consecutive hours.
• Perform Cranial Ultrasound only if platelets drop < 50,000, or if any neurologic symptoms manifest.

Management Limits

• Most infants require strictly observation alone.
• IVIG: Administer 1 g/kg IV (may repeat x1) if platelets drop < 30,000/mcL or if actively bleeding.
• Platelet Transfusion (Random Donor): Transfuse only if profound clinical bleeding, or if platelets < 20,000/mcL. (Note: Transfused platelets will also be destroyed by the circulating maternal autoantibody, providing only transient support).
• Recovery: The maternal antibody fully clears the infant's circulation within 4 to 12 weeks, leading to spontaneous complete recovery.

Diagnostic & Management Algorithm

• Maternal ITP Infant Protocol: [START] Mother with ITP -> [ACTION] Cord blood platelet count -> [DECISION] Plt < 30k or bleeding? -> [YES] IVIG -> [NO] Serial platelet checks days 1-5

References

1. Roberts I, Murray NA. Neonatal thrombocytopenia. Semin Fetal Neonatal Med.
2. Bussel JB. Autoimmune thrombocytopenic purpura. Hematol Oncol Clin North Am.